With the launch of the European Union’s Falsified Medicine Directive (EU FMD) on February 9, requirements for serialization, verification, and reporting are now an essential part of doing business within the EU. If you’re still looking for an EU FMD solution, or if your chosen solution is not up to the task, time is of the essence for your brand, for your business, and for the patients who rely on the medicines flowing through the EU supply chain.

This eBook is your guide to the post-launch EU FMD landscape, from regulatory updates to lessons learned to critical components needed for a successful solution. Learn how TraceLink’s vast experience and global digital supply network can help your business achieve compliance, overcome risk, and build value.